Effects of discontinuation of growth hormone treatment on body composition and metabolism.
This study was directed to the investigation of two different aspects of growth hormone: What are the metabolic consequences following the discontinuation of treatment and are these metabolic effects correlated with the growth-promoting effects seen in the first year of treatment? The study was performed on 12 growth hormone-deficient (GHD) patients who reached their final height. Each patient was matched with a non-GHD person of the same sex and about the same age. Immediately after the discontinuation of treatment, and 6 weeks and 6 months later, the following anthropometric variables were assessed: height, weight, skinfold thicknesses (biceps, triceps, subscapular and suprailiacal), body volume (underwater weighing) and total body water (deuterium dilution). To describe energy metabolism, basal metabolic rate assessed by ventilated hood, and sleep metabolic rate assessed by respiration chamber, were studied. Body composition was calculated from weight, volume and total body water. Clear metabolic effects were found after the discontinuation of treatment in GHD children: there was a decrease in fat free mass and sleep metabolic rate. Also, a strong correlation between the above-mentioned effects and the growth-promoting effects of human growth hormone at the beginning of the treatment was observed. The fact that this correlation exists poses the interesting question of whether the results from a test treatment lasting some weeks could be used to predict the long-term effects of hGH.
Gerver
W J
WJ
Department of Paediatrics, Maastricht University, The Netherlands. w.gerver@kg.unimaas.nl
De Bruin
R
R
Delemarre v d Waal
H A
HA
Aldewereld
B
B
Theunissen
P
P
Westerterp
K R
KR
D000293:Adolescent; D000328:Adult; D001481:Basal Metabolism; D001823:Body Composition / Q000187:drug effects*; D001835:Body Weight; D003903:Deuterium; D004334:Drug Administration Schedule; D004734:Energy Metabolism / Q000187:drug effects*; D005260:Female; D006128:Growth / Q000187:drug effects; D019382:Human Growth Hormone / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007101:Immersion; D007201:Indicator Dilution Techniques; D008297:Male; D012119:Respiration; D012885:Skinfold Thickness; D012890:Sleep / Q000502:physiology
D019382:Human Growth Hormone; D003903:Deuterium